GE HealthCare Technologies Inc. (NASDAQ:GEHC) Plans $0.04 Quarterly Dividend

GE HealthCare Technologies Inc. (NASDAQ:GEHC - Get Free Report) announced a quarterly dividend on Thursday, March 27th, RTT News reports. Investors of record on Friday, April 25th will be given a dividend of 0.035 per share on Thursday, May 15th. This represents a $0.14 annualized dividend and a yield of 0.17%. The ex-dividend date of this dividend is Friday, April 25th.

GE HealthCare Technologies has a payout ratio of 2.7% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect GE HealthCare Technologies to earn $5.20 per share next year, which means the company should continue to be able to cover its $0.14 annual dividend with an expected future payout ratio of 2.7%.

GE HealthCare Technologies Stock Up 0.9 %

Shares of GEHC stock traded up $0.70 during trading hours on Monday, hitting $80.71. 4,149,865 shares of the company's stock traded hands, compared to its average volume of 2,938,521. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The stock's fifty day simple moving average is $86.70 and its two-hundred day simple moving average is $85.86. GE HealthCare Technologies has a 12-month low of $74.51 and a 12-month high of $94.80. The stock has a market cap of $36.91 billion, a price-to-earnings ratio of 18.64, a PEG ratio of 3.19 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its earnings results on Thursday, February 13th. The company reported $1.45 EPS for the quarter, topping the consensus estimate of $1.26 by $0.19. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The business had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.33 billion. On average, analysts expect that GE HealthCare Technologies will post 4.68 EPS for the current year.

Remove Ads

Analysts Set New Price Targets

A number of equities analysts have weighed in on GEHC shares. Jefferies Financial Group raised GE HealthCare Technologies from a "hold" rating to a "buy" rating and boosted their target price for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. Wells Fargo & Company boosted their price objective on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the company an "overweight" rating in a report on Friday, February 14th. Citigroup lifted their price objective on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a "buy" rating in a research report on Thursday, February 13th. Finally, The Goldman Sachs Group raised shares of GE HealthCare Technologies from a "neutral" rating to a "buy" rating and increased their target price for the stock from $85.00 to $100.00 in a report on Tuesday, March 11th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $98.75.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.